53rd Annual Course in Electrodiagnostic Medicine: Clinical and Electrical Evaluation of the Peripheral Nervous System

The Annual Course in Electrodiagnostic Medicine is designed for clinicians involved in the diagnosis, treatment and prognosis of patients with peripheral nervous system diseases and injuries.

This course mixes didactic lectures, case presentations and audience response to introduce and reinforce new information and best clinical practices.

Learn and improve skills in:

• Basic concepts including membrane conduction physiology

• Firing pattern identification of voluntary and spontaneous wave forms as well as recruitment pattern analysis;

• Indications and contradictions for the use of botulinum toxin for treating spasticity and focal dystonias of the head and limbs;

• Differentiating axonal from demyelinating pathology as well as localization of site of nerve pathology based on electrical findings;

• Identifying anterior horn cell, radiculopathies, neuromuscular junction diseases and myopathies;

• Role of electrodiagnostics in guiding diagnosis and prognosis in a variety of peripheral nerve and neuromuscular conditions.

This activity has pre-conference modules that need to be completed before the start of the conference. The online modules can be found on the Course Content tab.

• Basic Conduction & Neuromuscular Junction (NMJ) Physiology (1.5 hours)

• Motor Unit Physiology (1.5 hours)

• Waveform Evaluation (1.0 hours)

• Late Responses: Uses & Pitfalls (2.0 hours)

• 2024 Muscle & Nerve Literature Updates (1.0 hours)

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Thursday, February 26, 2026. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Identify normal muscle membrane physiology, physiology of normal, neuropathic and myopathic voluntary motor unit potentials as well as firing patterns between muscle fiber and motor unit potentials.
2. Differentiate normal from abnormal recruitment frequency and ratio.
3. Identify common pathological needle electromyography waveforms.
4. Identify technical and physiologic factors that affect latency, conduction velocity, temporal dispersion, and amplitude including phase cancellation.
5. Recognize how late responses contribute to differentiating between axonopathies and myelinopathies at a proximal level, and how they contribute to diagnosis.
6. Describe neurapraxia, axonotmesis and intraneural neurotmesis based on the type, site and duration of nerve injury, and the classification of nerve injuries as a dynamic process.
7. Explain the components of electrodiagnostic equipment and the fundamentals of signal processing as it applies to electrodiagnostics.
8. Explain the basics of using electrodiagnostic and clinical information to prognosticate recovery from neural injury.
9. Categorize ulnar, peroneal and tibial nerve lesions based on the type, site and duration of injury.
10. Recognize importance of both the clinical and electrodiagnostic components in the evaluation of radiculopathies.
11. Describe how electrodiagnostic testing can be utilized to achieve optimal clinical outcomes and prevent unwanted complications.
12. Identify the indications and contraindications for the use of botulinum toxin.
13. Review the evidence for selecting appropriate localization modes and clinical scenarios that require multiple guidance techniques for chemodenervation.
14. Describe the clinical and histopathophysiology of neuromuscular junction disease.
15. Identify a clinical and electrical approach to myopathies and the major differentiating factors between the major types.
16. Describe the major clinical and electrodiagnostic features of ALS and other motor neuron diseases.
17. Identify the major clinical and electrodiagnostic mimics of motor neuron disease.
18. Identify the major benefits and limitations of neuromuscular ultrasound as part of the electrodiagnostic evaluation.
19. Identify common electrodiagnostic features and etiologies of peripheral polyneuropathy.
20. Identify key applicable updates from the recent electrodiagnostic literature.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 20.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

 Other Healthcare Professionals: This educational activity is designated for 20.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Agenda
Agenda subject to change without notice.

Cancellation Policy
Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies.  Email [email protected] - please include the activity name in the subject line. 

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Zoom information will be provided in pre-conference emails and on the Course Content tab.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Shawn M Peterson, DO
Assistant Professor
Thomas Jefferson University
Philadelphia, PA

Course Director, Faculty

Nothing to disclose

Jason D Berk, MD
Module Leader, Physical Medicine & Rehabilitation
Mid Atlantic Permanente Medical Group
Potomac, MD

Faculty

Andrew H Dubin, MD, MS
Professor of PM&R
University of Florida
Gainesville, FL

Faculty

Nothing to disclose

Kristofer J Feeko, DO
Assistant Professor Dept of Rehabilitation Medicine
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Mitchell Freedman, DO
Physician
Rothman Institute
Philadelphia, PA

Faculty

Nothing to disclose

Guy Fried, MD
Associate Chief Medical Officer
Jefferson Moss Magee Rehab
Philadelphia, PA

Faculty

Jeffrey A Gehret, DO
Rothman Orthopedics
Malvern , PA

Faculty

Ari Greis, DO
Rothman Orthopedics
Bryn Mawr, PA

Faculty

Hristelina Ilieva, MD, PhD
Assistant Professor
Jefferson ALS center
Philadelphia, PA

Faculty

Grant or research support-Healey Platform|Grant or research support-TechvsALS|Grant or research support-ALSA|Membership on Advisory Committees or Review Panels, Board Membership, etc.-ALSA (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AANEM|Honoraria-Department of Defence (Relationship has ended)

Kyle Marden, MD
Neuromuscular Fellow
Thomas Jefferson University Hospitals
Manalapan, NJ

Faculty

Levon Nazarian, MD
Professor and Chief of Musculoskeletal Imaging
Hospital of the University of Pennsylvania
Cherry Hill, NJ

Faculty

Nothing to disclose

Jeremy Simon, MD, FAAPMR
Division Chief, Assistant Professor
Rothman Orthopaedics and Thomas Jefferson University
Wallingford, PA

Faculty

Jessica J Yi, MD
Thomas Jefferson University Hospitals
Philadelphia, PA

Faculty

Grant or research support-Kyverna

Chrystyna Pospolyta, MPH
Project Manager
Thomas Jefferson University
Philadelphia, PA

Other Planning Committee Member

Nothing to disclose

Exhibitor Rules

• Exhibitor is not providing commercial support for this educational activity.

• Exhibitor is purchasing exhibit space.

• Exhibits are intended for informational purposes, products should not be sold through the exhibit hall.

• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitutes a payment or transfer of value to a covered participant, which is required to reported under the Sunshine Act.

• Exhibitors may observe educational sessions but must refrain from participating in the activity.

• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

Application Deadline
Applications for exhibits will be accepted through Thursday, February 5, 2026. After February 5, 2026, applications may be accepted on a case by case basis.

 Cancellation and Refunds
In the event that the symposium is canceled by the organizers, exhibit fees will be refunded in full, however Thomas Jefferson University is not responsible for other expenses incurred by the exhibitor.

• In the event an exhibitor cancels participation, refunds will be made as follows:

• Prior to the deadline of February 5, 2026 a refund will be given minus a 10% administration fee.

• After February 5, 2026 no refund will be given.

• Exhibitors who are absent from the conference will not receive a refund.

• Exhibit cancellations must be made in writing.

Send cancellation notice to [email protected] and include name of activity in subject line.